These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34129638)
21. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779 [TBL] [Abstract][Full Text] [Related]
22. Influenza vaccination prevalence and demographic factors of patients and GPs in primary care in Austria and Croatia: a cross-sectional comparative study in the framework of the APRES project. Hoffmann K; Paget J; Wojczewski S; Katic M; Maier M; Soldo D Eur J Public Health; 2016 Jun; 26(3):395-401. PubMed ID: 26936080 [TBL] [Abstract][Full Text] [Related]
23. Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season. Quattrocchi A; Mereckiene J; Fitzgerald M; Cotter S Vaccine; 2019 Oct; 37(43):6390-6396. PubMed ID: 31515147 [TBL] [Abstract][Full Text] [Related]
24. Associations between the prevalence of influenza vaccination and patient's knowledge about antibiotics: a cross-sectional study in the framework of the APRES-project in Austria. Hoffmann K; van Bijnen EM; George A; Kutalek R; Jirovsky E; Wojczewski S; Maier M BMC Public Health; 2015 Sep; 15():981. PubMed ID: 26416304 [TBL] [Abstract][Full Text] [Related]
25. Influenza vaccination 2014-2015: Results of a survey conducted among general practitioners in Italy. Levi M; Bonanni P; Biffino M; Conversano M; Corongiu M; Morato P; Maio T Hum Vaccin Immunother; 2018 Jun; 14(6):1342-1350. PubMed ID: 29451834 [TBL] [Abstract][Full Text] [Related]
26. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Blank PR; Schwenkglenks M; Szucs TD Infection; 2009 Oct; 37(5):390-400. PubMed ID: 19768382 [TBL] [Abstract][Full Text] [Related]
27. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Pierse N; Kelly H; Thompson MG; Bissielo A; Radke S; Huang QS; Baker MG; Turner N; Vaccine; 2016 Jan; 34(4):503-509. PubMed ID: 26685091 [TBL] [Abstract][Full Text] [Related]
28. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Valenciano M; Ciancio B; Euro Surveill; 2012 Sep; 17(39):. PubMed ID: 23041022 [TBL] [Abstract][Full Text] [Related]
30. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Kissling E; Rondy M; Euro Surveill; 2017 Feb; 22(7):. PubMed ID: 28230524 [TBL] [Abstract][Full Text] [Related]
31. Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the General Practice Research Database. Sammon CJ; McGrogan A; Snowball J; de Vries CS Vaccine; 2012 Mar; 30(14):2483-9. PubMed ID: 22133511 [TBL] [Abstract][Full Text] [Related]
32. Prevention and Control of Seasonal Influenza with Vaccines. Grohskopf LA; Sokolow LZ; Broder KR; Olsen SJ; Karron RA; Jernigan DB; Bresee JS MMWR Recomm Rep; 2016 Aug; 65(5):1-54. PubMed ID: 27560619 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and correlates of vaccine hesitancy among general practitioners: a cross-sectional telephone survey in France, April to July 2014. Verger P; Collange F; Fressard L; Bocquier A; Gautier A; Pulcini C; Raude J; Peretti-Watel P Euro Surveill; 2016 Nov; 21(47):. PubMed ID: 27918262 [TBL] [Abstract][Full Text] [Related]
34. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. Sullivan SG; Komadina N; Grant K; Jelley L; Papadakis G; Kelly H J Med Virol; 2014 Jun; 86(6):1017-25. PubMed ID: 24395730 [TBL] [Abstract][Full Text] [Related]
35. Cross-sectional survey: risk-averse French general practitioners are more favorable toward influenza vaccination. Massin S; Ventelou B; Nebout A; Verger P; Pulcini C Vaccine; 2015 Jan; 33(5):610-4. PubMed ID: 25545596 [TBL] [Abstract][Full Text] [Related]
36. Factors associated with childhood influenza vaccination in Israel: a cross-sectional evaluation. Glatman-Freedman A; Amir K; Dichtiar R; Zadka H; Vainer I; Karolinsky D; Enav T; Shohat T Isr J Health Policy Res; 2019 Nov; 8(1):82. PubMed ID: 31771629 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Nicholson KG; Abrams KR; Batham S; Clark TW; Hoschler K; Lim WS; Medina MJ; Nguyen-Van-Tam JS; Read RC; Warren FC; Zambon M Lancet Infect Dis; 2011 Feb; 11(2):91-101. PubMed ID: 21168369 [TBL] [Abstract][Full Text] [Related]
38. Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination. Tuckerman J; Crawford NW; Marshall HS PLoS One; 2020; 15(4):e0230425. PubMed ID: 32271793 [TBL] [Abstract][Full Text] [Related]
39. The provision of influenza vaccine to patients over 65 years by general practitioners. Bedford D; Howell F; Corcoran R Ir Med J; 1997 Oct; 90(6):231-2. PubMed ID: 9611925 [TBL] [Abstract][Full Text] [Related]
40. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Ryan J; Zoellner Y; Gradl B; Palache B; Medema J Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]